Natco Pharma Limited — Others, 14-11-2024: Copy of Newspaper Publication

Natco Pharma has announced a board meeting to discuss the revised record date for the declaration of the 2nd interim dividend for the fiscal year 2024-25. This development may strengthen shareholder sentiments given the proactive approach towards dividend distribution, indicating robust financial health and commitment to returning value to investors. The updated record date will allow shareholders to benefit from this interim dividend, reflecting the company's ongoing efforts to maintain a positive outlook.